Cohan, S. L., Lucassen, E. B., Romba, M. C., & Linch, S. N. (2019). Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis. Biomedicines.
Citação norma ChicagoCohan, Stanley L., Elisabeth B. Lucassen, Meghan C. Romba, and Stefanie N. Linch. "Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment As a Treatment Strategy for Relapsing Multiple Sclerosis." Biomedicines 2019.
MLA citiranjeCohan, Stanley L., Elisabeth B. Lucassen, Meghan C. Romba, and Stefanie N. Linch. "Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment As a Treatment Strategy for Relapsing Multiple Sclerosis." Biomedicines 2019.